about
Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy.Clinical indications for intravascular ultrasound imaging.Focus on the research utility of intravascular ultrasound - comparison with other invasive modalitiesLong-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database.Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease.Stent fracture and restenosis in the drug-eluting stent era.Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction.Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry).Very long sirolimus-eluting stent implantation for de novo coronary lesions.Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study.Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery.Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients.Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameter.Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings.Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis.Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome.Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.New approaches to ostial and bifurcation lesions.Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents.Sirolimus-eluting stent implantation for chronic total occlusion of the left main coronary artery.The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.Paclitaxel eluting stents for the treatment of angiographically non-significant atherosclerotic lesions.Intravenous versus intracoronary bolus of glycoprotein IIb/IIIa inhibitor administration during primary percutaneous coronary intervention on long-term left ventricular systolic and diastolic function.Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.The occupational effects of interventional cardiology: results from the WIN for Safety survey.Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) Initiative.Improved recanalization of chronic total coronary occlusions using an optical coherence reflectometry-guided guidewire.Noncardiac pathology exposed at coronary angiography for ST-segment elevation.Value of preprocedure multislice computed tomographic coronary angiography to predict the outcome of percutaneous recanalization of chronic total occlusionsReplyIatrogenic hyperkalaemiaThe CAPTIM study
P50
Q35177599-130A54F7-63ED-45B5-A519-124EBE9C4785Q37811096-C310DE93-9AB5-45DE-80C0-E9173D6DC8C7Q37833156-D7502F3A-1A91-4CA5-A81A-BCA0C30457C9Q39020659-C1BA503D-D904-4BAF-977C-784CF6E8187AQ44530606-57DDABAC-A6E9-47DE-BFD1-AD277B477177Q44706720-B603602B-3175-4BF7-9B1A-0F0035F8D8CAQ44771237-F00E1EE7-EB5F-49F2-8C89-5E6CFF562B9AQ44783802-0CAAB3E4-D2FE-4999-84FE-F92A3CC0D817Q44819053-3423E269-1B51-42C6-A4D0-292DE4F82679Q44830884-84FB92C3-E1C4-468A-91CD-4F14B3BF624AQ44851341-BFC81CBB-A1B7-40F2-AD91-1A4CD0494C31Q44890525-968BD982-7D18-4974-B3FB-F30C041AAF03Q44953157-BA4E892B-8478-48C7-9B57-4E3EDAA73DA6Q44953160-07C45D78-5624-4AAA-83E3-40454FDE9721Q44957019-7E025259-2D72-4E01-BE1C-3E00257F4490Q44957029-456F974E-F585-4A13-B08F-1105B1B04D78Q45089777-7F9F0C78-78C3-4E52-AD36-D0DDF12E7633Q45152236-7893A378-BACC-453A-A63E-3CCFC8549EE3Q45218595-74DA30B3-1624-410F-9753-AA595B6C87ABQ46401773-FFC8EE9E-A3DA-4AF8-A58A-E5F18CCB0314Q46420663-C663B022-F2F6-452E-BC78-058AD6FB6656Q46644197-EA401AD8-2A24-4DBA-BF5C-71204F7A1E7FQ50889972-F3410527-CB0D-4471-AE36-A57621434744Q51090336-7E2EAAAD-CF27-43F4-AB6E-3E7F2484A7F3Q51301886-3FC17B86-D258-46DF-9E01-C104242D00CDQ51590029-CF118A77-F41B-48EA-BFB8-DF127BC4827DQ51610157-E1FF9BB6-5272-4CEC-A6C4-006C16F8CAF5Q53065169-7EE01761-7DFB-457B-98CE-CAFF6C15A9EAQ57726485-256C848A-86EC-406D-B182-5008B32ACA17Q61651881-50032D31-1D5E-4B1C-A57C-4A41E3C3E63CQ63185731-E5FCC6F3-908F-44D6-A867-9F152B3F7F8DQ63185732-D696C260-80E8-4A2A-8070-DECAD640B8B7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angela Hoye
@ast
Angela Hoye
@en
Angela Hoye
@es
Angela Hoye
@nl
Angela Hoye
@sl
type
label
Angela Hoye
@ast
Angela Hoye
@en
Angela Hoye
@es
Angela Hoye
@nl
Angela Hoye
@sl
prefLabel
Angela Hoye
@ast
Angela Hoye
@en
Angela Hoye
@es
Angela Hoye
@nl
Angela Hoye
@sl
P106
P21
P31
P496
0000-0003-0577-2395